Since c-Abl inhibition in multiple models of ALS shows therapeutic effects [17,18,19], we tried to test whether c-Abl could post-translational regulate TDP-43, which is one of aggregation-prone proteins in ALS. Here, ABL1 is linked to amyotrophic lateral sclerosis.